Drug intelligence / Profile preview

Nature's Tears

Development stage: Unknown
Lead developer: Bio-Logic Aqua Technologies
Administration: Topical

Overview

Nature's Tears is a sterile water mist product, primarily known as Nature's Tears EyeMist, developed by Bio-Logic Aqua Technologies. In clinical research conducted by the Aultman Health Foundation, it was utilized as a sterile water placebo control in a Phase 4 study (NCT01843309). The trial evaluated the efficacy of vapocoolant sprays, specifically ethyl chloride, in reducing pain and increasing patient satisfaction during intravenous (IV) catheter insertion. Nature's Tears delivers a fine, pH-balanced mist of sterile water to the application site, providing a sensory control without the cryogenic or anesthetic properties of active vapocoolants.

Brand names: Nature's TearsNature's Tears EyeMist
Other names: Sterile water mist

Beyond the preview

Go deeper on Nature's Tears.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nature's Tears.

Explore the full profile